top of page

Mwandishi:

Mhariri:

Imeboreshwa:

ULY CLINIC

© Hairuhusiwi kukopi bila kibali cha ULYCLINIC

ULY CLINIC

28 Februari 2026, 14:16:03

Image-empty-state.png
Image-empty-state.png
Image-empty-state.png
Image-empty-state.png

Nephritic syndrome

23 Novemba 2020, 11:53:17

Nephritic syndrome refers to a group of glomerular disorders characterized by inflammation of the glomeruli, resulting in leakage of blood and moderate amounts of protein into urine, reduced glomerular filtration rate (GFR), and fluid retention.

Glomerular disease may arise from:

  • Primary renal disease, or

  • Secondary systemic disorders affecting the kidneys.

Unlike nephrotic syndrome, nephritic syndrome is primarily an inflammatory process, often presenting acutely and potentially progressing to acute kidney injury (AKI) if not promptly managed.


Pathophysiology

Inflammation of the glomerular capillary walls leads to:

  1. Damage to glomerular filtration barrier

  2. Leakage of red blood cells → haematuria

  3. Reduced filtration → decreased GFR

  4. Sodium and water retention

  5. Hypertension and oedema

Immune-mediated injury is the most common mechanism involving:

  • Immune complex deposition

  • Complement activation

  • Cellular inflammation


Common Causes


Primary Glomerular Diseases

  • Acute post-streptococcal glomerulonephritis (APSGN)

  • IgA nephropathy

  • Rapidly progressive glomerulonephritis

  • Membranoproliferative glomerulonephritis


Secondary Causes

  • Systemic lupus erythematosus

  • Vasculitis

  • Infective endocarditis

  • Hepatitis B or C infection

  • Henoch–Schönlein purpura

  • Goodpasture syndrome


Risk Factors

  • Recent streptococcal throat or skin infection

  • Autoimmune diseases

  • Chronic infections

  • Genetic susceptibility

  • Male sex (some forms)

  • Childhood or young adulthood

  • Exposure to nephrotoxic agents


Signs and Symptoms


Urinary Manifestations

  • Cola-colored or smoky urine

  • Visible or microscopic haematuria

  • Mild to moderate proteinuria

  • Reduced urine output (oliguria)


Fluid Retention Features

  • Periorbital oedema

  • Peripheral oedema

  • Rapid weight gain


Systemic Features

  • Hypertension

  • Fatigue

  • Headache

  • Shortness of breath

  • Nausea and vomiting


Severe Presentations

  • Pulmonary oedema

  • Hypertensive emergency

  • Acute kidney injury

  • Encephalopathy


Diagnostic Criteria

Diagnosis is based on clinical and laboratory findings:

  • Haematuria

  • Proteinuria

  • Reduced GFR or rising serum creatinine

  • Hypertension

  • Oedema


Investigations


Baseline Investigations

  • Renal function tests (urea, creatinine, electrolytes)

  • Urinalysis (RBCs, protein, casts)

  • Urine microscopy (RBC casts)

  • Urine culture

  • Complete blood count


Immunological and Etiological Tests

(Usually performed at tertiary level)

  • Complement levels (C3, C4)

  • Antistreptolysin O titre (ASO)

  • ANA and anti-dsDNA

  • ANCA

  • Anti-GBM antibodies

  • Hepatitis B and C screening

  • HIV testing


Imaging

  • Renal ultrasound (kidney size and obstruction)


Definitive Diagnosis

  • Renal biopsy when:

    • Rapid deterioration of renal function

    • Unclear diagnosis

    • Suspected rapidly progressive glomerulonephritis

    • Adult-onset nephritic syndrome

Important Note:Definitive treatment depends entirely on identifying the underlying cause.


Management

Management focuses on:

  • Stabilization

  • Control of fluid overload

  • Blood pressure management

  • Treatment of underlying disease

  • Prevention of renal failure


Pharmacological Management


1. Fluid Overload

  • Furosemide 80 mg IV bolus

    • May repeat depending on response


2. Hypertension Management

If:

  • Diastolic BP >100 mmHgOR

  • Systolic BP >150 mmHg

Amlodipine 5 mg orally

Additional antihypertensives may be required under specialist care.


3. Cause-Specific Therapy (Specialist Guided)

May include:

  • Antibiotics (post-infectious causes)

  • Corticosteroids

  • Immunosuppressants

  • Plasmapheresis (severe immune disease)

  • ACE inhibitors/ARBs after stabilization


4. Management of Complications

  • Dialysis for severe renal failure

  • Treatment of hyperkalaemia

  • Management of pulmonary oedema


Non-Pharmacological Management

  • Administer oxygen if respiratory distress present

  • Nurse patient in semi-Fowler’s position

  • Strict salt restriction

  • Restrict potassium-containing foods

  • Fluid restriction:

    10 mL/kg/day + visible fluid losses

  • Daily weight monitoring

  • Input–output chart monitoring

  • Avoid nephrotoxic medications


Complications

  • Acute kidney injury

  • Chronic kidney disease

  • Hypertensive crisis

  • Pulmonary oedema

  • Hyperkalaemia

  • Uraemia

  • End-stage renal disease


Prevention

Preventive strategies include:

  • Early treatment of streptococcal infections

  • Control of autoimmune diseases

  • Infection prevention

  • Avoidance of nephrotoxic drugs

  • Blood pressure control

  • Regular monitoring in high-risk patients

  • Early referral to specialist care


Referral Criteria

Immediate referral to nephrologist or tertiary hospital if:

  • Rapid decline in renal function

  • Severe hypertension

  • Oliguria or anuria

  • Pulmonary oedema

  • Suspected rapidly progressive glomerulonephritis

  • Electrolyte imbalance

  • Need for renal biopsy or dialysis


Patient Education

Patients and caregivers should be advised to:

  • Monitor urine color and output

  • Restrict salt intake

  • Adhere strictly to medications

  • Seek urgent care for breathlessness or reduced urine

  • Avoid herbal or over-the-counter nephrotoxic drugs

  • Attend follow-up renal assessments


Prognosis

Outcome varies depending on cause:

  • Post-streptococcal nephritis → usually good recovery (especially in children)

  • Autoimmune nephritis → variable progression

  • Rapidly progressive forms → may lead to permanent renal failure without early treatment


References

  1. KDIGO Clinical Practice Guideline for Glomerulonephritis. Kidney Int Suppl. 2021;11(3):1-150.

  2. Couser WG. Glomerulonephritis. Lancet. 2012;379(9813):331-340.

  3. Floege J, Amann K. Primary glomerulonephritides. Lancet. 2016;387:2036-2048.

  4. Johnson RJ, Feehally J, Floege J. Comprehensive Clinical Nephrology. 6th ed. Elsevier; 2019.

  5. KDOQI Clinical Practice Guidelines for Chronic Kidney Disease Evaluation and Management. Am J Kidney Dis. 2013;63(5 Suppl 2):S1-S150.

  6. Rodriguez-Iturbe B, Haas M. Post-streptococcal glomerulonephritis. N Engl J Med. 2017;376:954-963.


Imeandikwa:

bottom of page